title: Elevated free fatty acid concentrations in lipemic sera reduce protein binding of valproic acid significantly more than phenytoin.
abstract: Higher concentrations of free valproic acid and phenytoin have been reported in patients with uremia and liver disease. Free fatty acids also displace valproic acid and phenytoin. This is a study of the magnitude of displacement of valproic acid and phenytoin from protein binding by free fatty acid in lipemic sera. Higher concentrations of free fatty acids in lipemic sera affected protein binding of valproic acid significantly more than that of phenytoin. Supplementing normal sera with free fatty acids also increased the free concentrations of both valproic acid and phenytoin as expected, but the observed effect was several times higher in magnitude with valproic acid. There was an increased free fraction of valproic acid in patients who received valproic acid and had hypertriglyceridemia. In a patient with uremia, there was also a significant increase in free valproic acid concentration after routine hemodialysis caused by an increase in free fatty acid concentration secondary to hemodialysis. Increased protein binding of valproic acid in sera was observed after treatment with activated charcoal because charcoal can remove free fatty acid. Because higher free fatty acid concentration significantly affects protein binding of valproic acid, careful monitoring of free valproic acid in patients with lipid disorder may be beneficial.
authors.affiliation: Department of Pathology, University of New Mexico School of Medicine, Albuquerque 87106, USA.
authors.forename: A
authors.initials: A
authors.lastname: Dasgupta
authors.forename: M J
authors.initials: MJ
authors.lastname: Crossey
mesh_terms: D001663:Bilirubin / Q000097:blood / Q000378:metabolism; D001798:Blood Proteins / Q000378:metabolism; D002606:Charcoal / Q000494:pharmacology; D003404:Creatinine / Q000097:blood / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000097:blood / Q000494:pharmacology*; D006801:Humans; D006949:Hyperlipidemias / Q000378:metabolism*; D010672:Phenytoin / Q000097:blood / Q000378:metabolism*; D011485:Protein Binding / Q000187:drug effects*; D014280:Triglycerides / Q000097:blood / Q000378:metabolism; D014508:Urea / Q000097:blood / Q000378:metabolism; D014635:Valproic Acid / Q000097:blood / Q000378:metabolism*
chemical_list: D001798:Blood Proteins; D005230:Fatty Acids, Nonesterified; D014280:Triglycerides; D002606:Charcoal; D014635:Valproic Acid; D010672:Phenytoin; D014508:Urea; D003404:Creatinine; D001663:Bilirubin